Research on non psychoactive cannabis extract use for ASD symptoms
Free certificates of participation are available upon successful completion of a brief knowledge quiz: https://www.classmarker.com/online-test/start/?quiz=3kh5e275b21cdb6d
Learn about emerging research on the effectiveness of cannabidivarin (CBDV) on irritability and repetitive behaviors in children with ASD. CBDV is a non-psychoactive chemical compound and does not cause a “high” – research suggests cannabis extract holds hope for treating autism symptoms based on the success it’s had reducing seizure activity.
Eric Hollander, M.D. is a Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine and Director of the Autism and Obsessive Compulsive Spectrum Program, and the Anxiety and Depression Program, at Montefiore Medical Center and the Albert Einstein College of Medicine. Previously he served as the Esther and Joseph Klingenstein Professor and Chair of Psychiatry at the Mount Sinai School of Medicine and was Director of the Seaver and NY Autism Center of Excellence in New York City. Before then he served as Associate Professor of Clinical Psychiatry at the Columbia University College of Physicians and Surgeons in New York. Learn more: http://www.einstein.yu.edu/faculty/11986/eric-hollander/